Investigation into fetal toxicity by arsenic exposure to pregnant women

Placenta ◽  
2017 ◽  
Vol 59 ◽  
pp. 178
Author(s):  
Keisuke Okabe
2016 ◽  
Vol 28 (2) ◽  
pp. 76-81
Author(s):  
Selina Akhter Banu ◽  
Molly L Kile ◽  
David C Christiani ◽  
Qazi Qumruzzaman

Objective : There is growing concern that exposure to arsenic during pregnancy can have adverse effects on the developing fetus. To investigate the effect of arsenic exposure on reproductive health outcomes this study was carried out.Materials and methods : This prospective birth cohort study was carried out by Harvard School of Public Health and Dhaka Community Medical College & Hospital in 2004 through the Sirajdikhan and Birahimpur community clinics as a pilot project. The study included 421 pregnancies at the time of enrollment. Water samples were collected at the time of enrollment and within one month of delivery from the tubewell of each participant identified as their primary source of drinking water. These samples were analyzed by inductively coupled plasma mass spectrometry.Results: Of 421 pregnancies, 38 women withdrew from the study or were lost to follow up (9.0%), 30 resulted in spontaneous abortion or miscarriage (7.1%), 32 were stillbirths (7.6%) and 321 were live births (76.2%). At the time of enrollment, the average drinking water arsenic exposure level was 31.6 ?g/L (standard deviation, 83.7 ?g/L; range, <1 – 880 ?g/L). The average drinking water level at one month post delivery was 26.1 ?g/L (standard deviation, 68.2 ?g/L, range: <1 to 460 ?g/L) which indicated that exposure to arsenic contaminated drinking water decreased during pregnancy. However, 31.9% of all participants exceeded the World Health Organization’s recommended drinking water arsenic level of 10 ?g/L and 16.9% exceeded the Bangladesh drinking water arsenic regulation of 50 ?g/L. Sixty-three (40.9%) of all women reported an illness during this pregnancy. The odds of reporting any illness during the current pregnancy was 51% higher for those women who used a tubewell that contained more than the Bangladesh drinking water standard during their pregnancy compared to pregnant women who used a tubewell that contained less than 50 ?g As/L adjusting for maternal age, maternal education, and pregnancy history (odds ratio, 1.51; 95% confidence interval, 0.28, 8.16). Of the 321 live births, 64 (15.2%) had a birthweight less than 2500 grams and were classified as low birthweight. The odds of a low birthweight infant was 32.3% greater for those women who used a tubewell that contained more than the Bangladesh drinking water standard during their pregnancy compared to pregnant women who used a tubewell that contained less than 50 ?g As/L adjusting for maternal age, maternal education, gestational age, infant sex, spouses education, mother’s weight gain during the first 28 weeks, chewing betel nuts, reporting any illness during pregnancy, environmental tobacco smoke, and pregnancy history (odds ratio, 1.32; 95% confidence interval, 0.19, 9.17). In this sample, 35 infants were born at less than 37 weeks gestational age (8.3%) and were classified as preterm infants. The odds of a preterm infant was 84% greater for those women who used a tubewell that contained more than the Bangladesh drinking water standard during their pregnancy compared to pregnant women who used a tubewell that contained less than 50 ?g As/L adjusting for maternal age, maternal education, spouses education, mother’s weight gain during the first 28 weeks, environmental tobacco smoke, and pregnancy history (odds ratio, 1.84; 95% confidence interval, 0.81, 4.17).Conclusion: Arsenic exposure during pregnancy contributed to adverse maternal – child health outcomes. It is important to note that none of these associations reached statistical significant and it will be important to confirm these associations in the complete dataset.Bangladesh J Obstet Gynaecol, 2013; Vol. 28(2) : 76-81


2017 ◽  
Vol 1479 ◽  
pp. 145-152 ◽  
Author(s):  
Han Li ◽  
Mu Wang ◽  
Qiande Liang ◽  
Shuna Jin ◽  
Xiaojie Sun ◽  
...  

2007 ◽  
Vol 1 (1) ◽  
pp. 21-29
Author(s):  
Lorenzo Pradelli

Vulvo-vaginal infections are the most common gynaecological pathologies seen in clinical practice. While being predominantly benign, although disturbing, in non pregnant women, their presence during pregnancy has been associated with peri-natal and obstetric complications. The opportunity to prevent these adverse outcomes, especially prematurity and low birth weight, has to be cautiously balanced against the potential to induce fetal toxicity, inherently related to the continuous exchanges among maternal and fetal blood that occurs in the placenta. In this paper, a brief overview of the evidence regarding efficacy, safety and utility during pregnancy of topical clotrimazole and metronidazole, whose combined spectrum covers the great majority of the involved pathogens, is provided. These antimicrobials, especially when applied topically, are highly effective and have been used in pregnant women for many years without evidence of adverse outcomes; in conclusion it appears that they hold an adequate risk-to-benefit ratio and represent valid therapeutic options in the treatment of vulvo-vaginal infections during pregnancy.


2005 ◽  
Vol 44 (159) ◽  
Author(s):  
Pravin Nepal ◽  
G K Singh ◽  
M P Singh ◽  
S Bajracharya ◽  
G P Khanal ◽  
...  

Osteosarcoma in pregnant women is rare. Delay in diagnosis may be due to lack of any signs or symptomsduring gestation, clinical misdiagnoses, religious attitude and refusal of the patients. Most cases soft-tissueand bone tumors during pregnancy can be managed successfully with surgery during gestation. Therapieswith fetal toxicity were more likely to be deferred to postpartum period. This case is rare and liable to bemissed, hence is reported.


2021 ◽  
Vol 222 ◽  
pp. 112527
Author(s):  
Xin Wang ◽  
Yi Wu ◽  
Xiaojie Sun ◽  
Qing Guo ◽  
Wei Xia ◽  
...  

2020 ◽  
Vol 36 (3) ◽  
pp. 181-213
Author(s):  
Zengjin Wang ◽  
Zhiping Wang

Applications of nanomaterials cause a general concern on their toxicity when they intentionally (such as in medicine) or unintentionally (environment exposure) enter into the human body. As a special subpopulation, pregnant women are more susceptible to nanoparticle (NP)-induced toxicity. More importantly, prenatal exposures may affect the entire life of the fetus. Through blood circulation, NPs may cross placental barriers and enter into fetus. A cascade of events, such as damage in placental barriers, generation of oxidative stress, inflammation, and altered gene expression, may induce delayed or abnormal fetal development. The physicochemical properties of NPs, exposure time, and other factors directly affect nanotoxicity in pregnant populations. Even though results from animal studies cannot directly extrapolate to humans, compelling evidence has already shown that, for pregnant women, caution must be taken when dealing with nanomedicines or NP pollutants.


2014 ◽  
Vol 2014 (1) ◽  
pp. 2274
Author(s):  
María Pía Muñoz* ◽  
Verónica Iglesias ◽  
Macarena Valdés ◽  
María Teresa Muñoz-Quezada ◽  
Boris Lucero ◽  
...  

1998 ◽  
Vol 5 (1) ◽  
pp. 143A-143A ◽  
Author(s):  
G DILDY ◽  
C LOUCKS ◽  
T PORTER ◽  
C SULLIVAN ◽  
M BELFORT ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document